NEUMORA THERAPEUTICS INC (NMRA)
US6409791000 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to NMRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 25.76. This target is 160.15% above the current price.
NMRA was analyzed by 12 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about NMRA.
In the previous month the buy percentage consensus was at a similar level.
NMRA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-10 | Guggenheim | Initiate | Buy |
| 2023-10-10 | William Blair | Initiate | Outperform |
| 2023-10-10 | RBC Capital | Initiate | Outperform |
| 2023-10-10 | Stifel | Initiate | Buy |
| 2023-10-10 | JP Morgan | Initiate | Overweight |
| 2023-10-10 | B of A Securities | Initiate | Buy |